SCHEDULE 13G/A: AIGH Capital Management and Orin Hirschman Disclose Significant 8.5% Stake in IN8bio, Inc.

AIGH Capital Management LLC and Orin Hirschman have disclosed a combined beneficial ownership of 8.5% of IN8bio, Inc.'s common stock as of December 31, 2024.

Summary

• Orin Hirschman and AIGH Capital Management LLC, along with AIGH Investment Partners, L.L.C., collectively reported beneficial ownership of 6,191,865 shares of IN8bio, Inc. common stock.
• This ownership represents 8.5% of the company's outstanding common stock.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported beneficial ownership.
• Warrants to purchase an additional 13,260,016 common shares were excluded from the beneficial ownership calculation due to beneficial ownership limitations on exercise.

Sentiment

Score: 6

Explanation: The disclosure of a significant ownership stake by an investment firm can be viewed as a neutral to slightly positive signal, indicating institutional interest in the company, though it provides no operational or financial performance details.

Positives

• The disclosure of a significant 8.5% stake by AIGH Capital Management and Orin Hirschman may signal confidence from a notable investment entity in IN8bio, Inc.
• The substantial number of shares beneficially owned (6,191,865) indicates a material investment by the reporting persons.

Risks

• The filing notes that warrants to purchase 13,260,016 common shares are excluded from the beneficial ownership calculation due to beneficial ownership limitations on exercise, which could imply potential future dilution if these limitations are lifted or if the warrants are exercised by other parties.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding IN8bio, Inc.'s future performance or strategic outlook.

Management Comments

• The reporting persons certified that the securities were acquired and are held in the ordinary course of business and not for the purpose or with the effect of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

This filing is a standard regulatory disclosure of a significant ownership stake by an investment firm. It does not provide specific insights into broader industry trends or competitive dynamics, but rather reflects an investment decision within the sector IN8bio, Inc. operates in.

Stakeholder Impact

• Shareholders: May view the significant stake by AIGH Capital Management and Orin Hirschman as a positive indicator of institutional confidence and potential long-term interest in IN8bio, Inc.

Key Dates

Keywords

IN8bio, Schedule 13G, beneficial ownership, AIGH Capital Management, Orin Hirschman, common stock, investment